Free Trial

Alkami Technology (ALKT) Financials

Alkami Technology logo
$16.85 -0.32 (-1.86%)
Closing price 04:00 PM Eastern
Extended Trading
$17.01 +0.16 (+0.94%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Alkami Technology

Annual Income Statements for Alkami Technology

This table shows Alkami Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-43 -57 -47 -59 -63 -41 -48
Consolidated Net Income / (Loss)
-42 -51 -47 -59 -63 -41 -48
Net Income / (Loss) Continuing Operations
-42 -51 -47 -59 -63 -41 -48
Total Pre-Tax Income
-42 -51 -47 -59 -63 -41 -59
Total Operating Income
-43 -35 -43 -58 -64 -45 -54
Total Gross Profit
30 59 84 108 144 197 257
Total Revenue
74 112 152 204 265 334 444
Operating Revenue
74 112 152 204 265 334 444
Total Cost of Revenue
43 53 68 96 121 137 187
Operating Cost of Revenue
43 53 68 96 121 137 187
Total Operating Expenses
73 94 127 166 208 241 310
Selling, General & Admin Expense
25 36 50 71 73 84 101
Marketing Expense
15 17 24 37 49 60 80
Research & Development Expense
33 40 49 69 85 96 118
Amortization Expense
- - - - - - 5.69
Impairment Charge
- - - - 0.00 0.00 1.66
Restructuring Charge
- 0.84 2.98 -13 0.26 0.20 3.46
Total Other Income / (Expense), net
0.67 -16 -3.73 -1.37 0.84 4.10 -5.33
Interest Expense
0.11 0.49 1.19 3.87 7.79 0.46 9.49
Interest & Investment Income
0.27 0.06 0.49 2.70 8.10 4.56 4.16
Other Income / (Expense), net
0.51 -16 -3.04 -0.20 0.53 0.00 0.00
Income Tax Expense
0.00 0.00 0.17 -0.46 0.04 0.31 -11
Basic Earnings per Share
($9.91) ($11.78) ($0.73) ($0.64) ($0.67) ($0.41) ($0.46)
Weighted Average Basic Shares Outstanding
4.35M 4.81M 64.51M 90.96M 94.08M 98.89M 103.90M
Diluted Earnings per Share
($9.91) ($11.78) ($0.73) ($0.64) ($0.67) ($0.41) ($0.46)
Weighted Average Diluted Shares Outstanding
4.35M 4.81M 64.51M 90.96M 94.08M 98.89M 103.90M
Weighted Average Basic & Diluted Shares Outstanding
- - 90.22M 92.30M 96.76M 102.23M 106.15M

Quarterly Income Statements for Alkami Technology

This table shows Alkami Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-18 -15 -13 -11 -12 -9.44 -7.64 -7.82 -14 -15 -11
Consolidated Net Income / (Loss)
-18 -15 -13 -11 -12 -9.44 -7.64 -7.82 -14 -15 -11
Net Income / (Loss) Continuing Operations
-18 -15 -13 -11 -12 -9.44 -7.64 -7.82 -14 -15 -11
Total Pre-Tax Income
-18 -15 -13 -11 -12 -9.46 -7.69 -15 -18 -15 -11
Total Operating Income
-18 -16 -13 -12 -13 -10 -8.63 -15 -16 -13 -9.50
Total Gross Profit
35 37 40 44 49 51 53 58 66 64 69
Total Revenue
66 68 71 76 82 86 90 98 112 113 121
Operating Revenue
66 68 71 76 82 86 90 98 112 113 121
Total Cost of Revenue
30 31 31 32 33 35 36 40 46 49 52
Operating Cost of Revenue
30 31 31 32 33 35 36 40 46 49 52
Total Operating Expenses
53 52 53 56 62 61 62 73 81 77 79
Selling, General & Admin Expense
18 18 19 19 21 22 22 24 26 26 25
Marketing Expense
14 12 12 14 17 14 15 18 23 19 20
Research & Development Expense
21 22 21 23 24 24 25 27 30 30 31
Restructuring Charge
0.03 0.00 0.04 0.06 0.14 0.00 - 2.38 0.51 0.25 0.33
Total Other Income / (Expense), net
0.20 0.35 0.11 1.12 1.08 0.97 0.94 0.30 -2.02 -1.95 -1.65
Interest Expense
1.83 1.93 2.28 0.07 0.07 0.18 0.13 0.80 3.19 2.98 2.52
Interest & Investment Income
2.02 2.08 2.27 1.08 1.26 1.15 1.07 1.10 1.16 1.03 0.87
Income Tax Expense
0.09 0.04 -0.28 0.19 0.19 -0.02 -0.05 -7.29 -4.30 -0.03 0.30
Basic Earnings per Share
($0.19) ($0.16) ($0.14) ($0.12) ($0.13) ($0.09) ($0.07) ($0.08) ($0.13) ($0.14) ($0.11)
Weighted Average Basic Shares Outstanding
93.33M 94.68M 94.08M 96.95M 98.10M 99.44M 98.89M 102.43M 103.39M 104.35M 103.90M
Diluted Earnings per Share
($0.19) ($0.16) ($0.14) ($0.12) ($0.13) ($0.09) ($0.07) ($0.08) ($0.13) ($0.14) ($0.11)
Weighted Average Diluted Shares Outstanding
93.33M 94.68M 94.08M 96.95M 98.10M 99.44M 98.89M 102.43M 103.39M 104.35M 103.90M
Weighted Average Basic & Diluted Shares Outstanding
94.23M 95.36M 96.76M 97.52M 98.99M 100.50M 102.23M 103.02M 104.08M 105.00M 106.15M

Annual Cash Flow Statements for Alkami Technology

This table details how cash moves in and out of Alkami Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-13 160 141 -201 -71 53 -31
Net Cash From Operating Activities
-39 -38 -29 -38 -18 19 43
Net Cash From Continuing Operating Activities
-39 -38 -29 -38 -18 19 43
Net Income / (Loss) Continuing Operations
-42 -51 -47 -59 -63 -41 -48
Consolidated Net Income / (Loss)
-42 -51 -47 -59 -63 -41 -48
Depreciation Expense
2.23 2.78 3.44 8.08 11 11 27
Amortization Expense
0.04 0.06 0.05 0.13 0.14 0.21 1.95
Non-Cash Adjustments To Reconcile Net Income
1.25 18 18 44 48 58 77
Changes in Operating Assets and Liabilities, net
-0.74 -7.40 -3.20 -32 -13 -9.65 -15
Net Cash From Investing Activities
-3.69 -27 -22 -224 34 23 -398
Net Cash From Continuing Investing Activities
-3.69 -27 -22 -224 34 23 -398
Purchase of Property, Plant & Equipment
-3.69 -2.15 -3.70 -4.45 -6.29 -7.86 -8.69
Acquisitions
0.00 -25 -18 -132 0.00 0.00 -375
Purchase of Investments
- 0.00 0.00 -187 -141 -40 -45
Sale and/or Maturity of Investments
- 0.00 0.00 100 181 71 32
Net Cash From Financing Activities
30 225 192 61 -88 12 324
Net Cash From Continuing Financing Activities
30 225 192 61 -88 12 324
Repayment of Debt
-0.11 -13 -0.31 -25 -85 -0.36 -47
Issuance of Debt
0.00 38 0.00 85 0.00 0.00 396
Issuance of Common Equity
0.00 0.00 196 2.91 4.12 4.74 5.34
Other Financing Activities, net
0.31 1.99 9.76 -1.27 -6.60 7.42 -30
Cash Interest Paid
0.06 0.35 1.10 3.61 7.06 0.28 5.94
Cash Income Taxes Paid
0.08 0.07 0.03 0.25 0.33 0.38 0.68

Quarterly Cash Flow Statements for Alkami Technology

This table details how cash moves in and out of Alkami Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-25 -14 -38 3.25 17 20 13 -33 -9.23 4.89 6.14
Net Cash From Operating Activities
-5.71 3.13 -5.31 0.95 0.55 11 6.11 -5.66 1.16 31 17
Net Cash From Continuing Operating Activities
-5.71 3.13 -5.31 0.95 0.55 11 6.11 -5.66 1.16 31 17
Net Income / (Loss) Continuing Operations
-18 -15 -13 -11 -12 -9.44 -7.64 -7.82 -14 -15 -11
Consolidated Net Income / (Loss)
-18 -15 -13 -11 -12 -9.44 -7.64 -7.82 -14 -15 -11
Depreciation Expense
2.56 2.70 2.79 2.56 2.61 2.68 2.65 3.43 7.76 7.87 7.86
Amortization Expense
0.04 0.03 0.03 0.03 0.03 0.10 0.05 0.19 0.59 0.58 0.58
Non-Cash Adjustments To Reconcile Net Income
12 12 12 13 15 15 15 17 19 21 20
Changes in Operating Assets and Liabilities, net
-2.76 3.87 -7.86 -3.36 -4.41 2.54 -4.42 -19 -13 17 -0.06
Net Cash From Investing Activities
-16 -16 50 6.81 15 3.77 -3.01 -389 -2.95 -1.10 -4.13
Net Cash From Continuing Investing Activities
-16 -16 50 6.81 15 3.77 -3.01 -389 -2.95 -1.10 -4.13
Purchase of Property, Plant & Equipment
-1.71 -1.54 -1.68 -1.67 -2.08 -2.30 -1.81 -1.93 -2.16 -2.32 -2.28
Purchase of Investments
-42 -47 -31 -7.15 -8.44 -15 -9.70 -22 -8.09 -5.88 -9.35
Sale and/or Maturity of Investments
28 32 83 16 26 21 8.50 9.90 7.30 7.10 7.50
Net Cash From Financing Activities
-3.45 -0.78 -83 -4.51 1.24 4.77 10 362 -7.44 -25 -6.34
Net Cash From Continuing Financing Activities
-3.45 -0.78 -83 -4.51 1.24 4.77 10 362 -7.44 -25 -6.34
Repayment of Debt
- -1.06 -83 0.00 - -0.36 - -0.78 -11 -25 -10
Issuance of Common Equity
- - 1.72 - - - 2.14 - - - 2.40
Other Financing Activities, net
-4.46 0.28 -1.86 -4.51 -1.36 5.13 8.16 -32 0.73 0.19 1.27

Annual Balance Sheets for Alkami Technology

This table presents Alkami Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
249 437 489 400 437 847
Total Current Assets
193 345 242 149 181 187
Cash & Equivalents
167 309 109 41 94 63
Short-Term Investments
- 0.00 88 51 21 36
Accounts Receivable
14 21 26 35 39 51
Prepaid Expenses
7.60 9.49 12 11 14 21
Other Current Assets
4.75 6.27 7.86 10 13 16
Plant, Property, & Equipment, net
10 12 14 17 22 27
Total Noncurrent Assets
45 80 233 234 234 633
Goodwill
16 48 148 148 148 403
Intangible Assets
8.27 11 43 36 29 159
Other Noncurrent Operating Assets
21 20 43 50 57 71
Total Liabilities & Shareholders' Equity
249 437 489 400 437 847
Total Liabilities
69 92 155 75 80 485
Total Current Liabilities
20 33 42 39 46 90
Accounts Payable
0.36 3.65 4.29 7.48 6.13 5.84
Accrued Expenses
13 19 22 20 25 47
Current Deferred Revenue
6.71 8.90 8.84 11 14 35
Other Current Liabilities
- 0.00 3.66 1.21 1.34 1.58
Total Noncurrent Liabilities
49 59 113 35 35 396
Long-Term Debt
25 23 81 - 0.00 351
Noncurrent Deferred Revenue
20 19 14 15 16 26
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 0.09 1.71 1.71 1.82 2.63
Other Noncurrent Operating Liabilities
4.09 17 16 18 17 16
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-264 345 334 325 357 362
Total Preferred & Common Equity
-264 345 334 325 357 362
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-264 345 334 325 357 362
Common Stock
0.01 658 706 760 833 886
Retained Earnings
-264 -314 -372 -435 -476 -524

Quarterly Balance Sheets for Alkami Technology

This table presents Alkami Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
485 482 473 482 398 404 422 837 840 835
Total Current Assets
255 237 226 233 146 152 169 174 178 175
Cash & Equivalents
97 114 90 76 44 61 81 62 52 57
Short-Term Investments
112 71 86 102 43 26 20 34 35 34
Accounts Receivable
26 28 28 31 36 39 42 47 48 51
Prepaid Expenses
13 14 13 14 12 14 14 19 28 18
Other Current Assets
7.05 8.44 8.92 9.50 11 11 12 14 15 15
Plant, Property, & Equipment, net
13 14 15 16 18 20 21 23 24 25
Total Noncurrent Assets
217 231 231 233 234 232 232 640 638 635
Goodwill
146 148 148 148 148 148 148 400 404 403
Intangible Assets
44 41 39 38 34 32 31 179 172 166
Other Noncurrent Operating Assets
26 42 44 48 52 52 53 61 62 66
Total Liabilities & Shareholders' Equity
485 482 473 482 398 404 422 837 840 835
Total Liabilities
157 154 150 161 75 77 84 503 496 485
Total Current Liabilities
40 42 42 49 37 41 48 63 66 81
Accounts Payable
3.21 3.16 1.05 5.69 6.53 5.79 5.59 5.18 6.70 7.26
Accrued Expenses
25 22 23 26 17 21 28 27 31 41
Current Deferred Revenue
9.42 9.85 8.81 9.31 12 13 13 29 27 31
Other Current Liabilities
- 3.12 3.17 1.49 1.24 1.28 1.31 1.56 1.58 1.58
Total Noncurrent Liabilities
117 112 109 111 38 36 36 440 430 404
Long-Term Debt
82 80 78 76 - - - 395 385 361
Capital Lease Obligations
- 16 - 18 18 - 17 17 - 16
Noncurrent Deferred Revenue
18 14 14 15 18 16 16 26 26 25
Noncurrent Deferred & Payable Income Tax Liabilities
0.34 1.79 1.83 1.86 1.74 1.76 1.77 2.35 2.41 2.45
Other Noncurrent Operating Liabilities
16 0.35 15 0.38 0.23 18 0.22 0.22 17 0.23
Total Equity & Noncontrolling Interests
328 328 323 322 323 327 339 334 344 350
Total Preferred & Common Equity
328 328 323 322 323 327 339 334 344 350
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
328 328 323 322 323 327 339 334 344 350
Common Stock
695 718 730 744 770 786 807 818 842 863
Retained Earnings
-368 -389 -407 -423 -447 -459 -469 -484 -498 -512

Annual Metrics And Ratios for Alkami Technology

This table displays calculated financial ratios and metrics derived from Alkami Technology's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 52.49% 35.68% 34.25% 29.65% 26.06% 32.89%
EBITDA Growth
0.00% -20.95% 11.70% -17.01% -5.48% 35.29% 26.94%
EBIT Growth
0.00% -21.17% 9.76% -25.98% -9.12% 29.36% -20.19%
NOPAT Growth
0.00% 17.47% -22.26% -34.42% -10.43% 29.95% -20.19%
Net Income Growth
0.00% -22.66% 8.83% -25.15% -7.36% 35.09% -16.69%
EPS Growth
0.00% -18.87% 93.80% 12.33% -4.69% 38.81% -12.20%
Operating Cash Flow Growth
0.00% 2.41% 24.08% -31.38% 54.00% 206.26% 130.71%
Free Cash Flow Firm Growth
0.00% 0.00% 15.29% -282.17% 72.70% 27.97% -933.42%
Invested Capital Growth
0.00% 0.00% 60.32% 266.51% 4.75% 3.64% 154.54%
Revenue Q/Q Growth
0.00% 0.00% 6.37% 6.85% 6.36% 5.80% 7.55%
EBITDA Q/Q Growth
0.00% 0.00% -1.31% 15.77% -16.75% 11.13% 16.42%
EBIT Q/Q Growth
0.00% 0.00% -1.75% 11.86% -13.99% 8.90% -1.65%
NOPAT Q/Q Growth
0.00% 0.00% -4.37% 11.56% -13.58% 9.11% -1.65%
Net Income Q/Q Growth
0.00% 0.00% -1.88% 12.59% -14.15% 11.04% -8.66%
EPS Q/Q Growth
0.00% 0.00% 84.73% -166.67% -15.52% 14.58% -9.52%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 9.01% -4.59% 32.74% 158.98% 32.38%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -4.56% 31.00% 11.88% 1.83%
Invested Capital Q/Q Growth
0.00% 0.00% 8.23% 9.19% -4.67% -5.34% -3.44%
Profitability Metrics
- - - - - - -
Gross Margin
41.39% 52.75% 55.08% 53.03% 54.42% 58.90% 57.84%
EBITDA Margin
-54.06% -42.88% -27.90% -24.32% -19.79% -10.16% -5.58%
Operating Margin
-57.84% -31.30% -28.20% -28.24% -24.06% -13.37% -12.09%
EBIT Margin
-57.15% -45.41% -30.20% -28.34% -23.85% -13.37% -12.09%
Profit (Net Income) Margin
-56.93% -45.79% -30.77% -28.69% -23.76% -12.23% -10.74%
Tax Burden Percent
100.00% 100.00% 100.37% 99.22% 100.07% 100.76% 80.82%
Interest Burden Percent
99.63% 100.85% 101.52% 102.02% 99.52% 90.81% 109.93%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -129.91% -61.01% -28.55% -19.60% -13.18% -8.78%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -92.17% -53.13% -19.34% -1.63% -3.94% -23.60%
Return on Net Nonoperating Assets (RNNOA)
0.00% 72.77% 43.15% 11.28% 0.50% 1.20% -4.48%
Return on Equity (ROE)
0.00% -57.14% -17.86% -17.27% -19.09% -11.98% -13.25%
Cash Return on Invested Capital (CROIC)
0.00% -329.91% -107.35% -142.80% -24.23% -16.75% -95.95%
Operating Return on Assets (OROA)
0.00% -20.44% -13.40% -12.51% -14.22% -10.66% -8.35%
Return on Assets (ROA)
0.00% -20.61% -13.66% -12.66% -14.16% -9.76% -7.42%
Return on Common Equity (ROCE)
0.00% 83.78% -2.76% -17.27% -19.09% -11.98% -13.25%
Return on Equity Simple (ROE_SIMPLE)
0.00% 19.49% -13.59% -17.54% -19.36% -11.44% 0.00%
Net Operating Profit after Tax (NOPAT)
-30 -25 -30 -40 -45 -31 -38
NOPAT Margin
-40.49% -21.91% -19.74% -19.77% -16.84% -9.36% -8.46%
Net Nonoperating Expense Percent (NNEP)
0.00% -37.75% -7.88% -9.21% -17.97% -9.23% 14.82%
Return On Investment Capital (ROIC_SIMPLE)
- - - -9.65% -13.72% -8.75% -5.26%
Cost of Revenue to Revenue
58.61% 47.25% 44.92% 46.97% 45.58% 41.10% 42.16%
SG&A Expenses to Revenue
33.89% 32.49% 33.12% 34.88% 27.53% 25.06% 22.74%
R&D to Revenue
44.49% 35.86% 32.07% 33.94% 31.97% 28.82% 26.69%
Operating Expenses to Revenue
99.22% 84.05% 83.28% 81.27% 78.47% 72.27% 69.93%
Earnings before Interest and Taxes (EBIT)
-42 -51 -46 -58 -63 -45 -54
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-40 -48 -42 -50 -52 -34 -25
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 5.13 4.00 7.12 10.32 6.69
Price to Tangible Book Value (P/TBV)
0.00 0.00 6.20 9.30 16.39 20.48 0.00
Price to Revenue (P/Rev)
2.45 1.61 11.62 6.53 8.73 11.04 5.46
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 12.72 24.47 5.50 9.54 14.80 4.35
Enterprise Value to Revenue (EV/Rev)
0.00 4.29 9.75 5.99 8.38 10.69 6.03
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 191.99 62.34
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.14 0.07 0.25 0.00 0.00 0.97
Long-Term Debt to Equity
0.00 0.14 0.07 0.24 0.00 0.00 0.97
Financial Leverage
0.00 -0.79 -0.81 -0.58 -0.31 -0.30 0.19
Leverage Ratio
0.00 1.39 1.31 1.36 1.35 1.23 1.79
Compound Leverage Factor
0.00 1.40 1.33 1.39 1.34 1.11 1.96
Debt to Total Capital
0.00% 12.16% 6.67% 20.20% 0.00% 0.00% 49.24%
Short-Term Debt to Total Capital
0.00% 0.15% 0.42% 0.76% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 12.01% 6.24% 19.44% 0.00% 0.00% 49.24%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 216.63% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -128.79% 93.33% 79.80% 100.00% 100.00% 50.76%
Debt to EBITDA
0.00 -0.52 -0.58 -1.70 0.00 0.00 -14.18
Net Debt to EBITDA
0.00 2.95 6.69 2.25 0.00 0.00 -10.18
Long-Term Debt to EBITDA
0.00 -0.51 -0.54 -1.64 0.00 0.00 -14.18
Debt to NOPAT
0.00 -1.01 -0.82 -2.09 0.00 0.00 -9.35
Net Debt to NOPAT
0.00 5.78 9.45 2.77 0.00 0.00 -6.72
Long-Term Debt to NOPAT
0.00 -1.00 -0.77 -2.02 0.00 0.00 -9.35
Altman Z-Score
0.00 0.68 11.40 4.62 17.47 26.84 2.58
Noncontrolling Interest Sharing Ratio
0.00% 246.61% 84.54% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 9.43 10.40 5.82 3.77 3.98 2.09
Quick Ratio
0.00 8.83 9.92 5.35 3.24 3.39 1.68
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -62 -53 -202 -55 -40 -410
Operating Cash Flow to CapEx
-1,059.50% -1,776.67% -783.31% -855.91% -278.16% 236.75% 493.80%
Free Cash Flow to Firm to Interest Expense
0.00 -127.61 -44.57 -52.23 -7.08 -86.15 -43.27
Operating Cash Flow to Interest Expense
-355.32 -78.01 -24.42 -9.84 -2.25 40.34 4.52
Operating Cash Flow Less CapEx to Interest Expense
-388.85 -82.40 -27.53 -10.99 -3.05 23.30 3.61
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.45 0.44 0.44 0.60 0.80 0.69
Accounts Receivable Turnover
0.00 7.95 8.71 8.68 8.58 8.99 9.83
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 10.72 13.65 16.09 17.36 17.11 18.21
Accounts Payable Turnover
0.00 147.18 34.10 24.17 20.51 20.17 31.25
Days Sales Outstanding (DSO)
0.00 45.90 41.89 42.05 42.55 40.58 37.12
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 2.48 10.70 15.10 17.79 18.10 11.68
Cash Conversion Cycle (CCC)
0.00 43.42 31.18 26.95 24.76 22.49 25.44
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 38 61 222 233 241 614
Invested Capital Turnover
0.00 5.93 3.09 1.44 1.16 1.41 1.04
Increase / (Decrease) in Invested Capital
0.00 38 23 162 11 8.48 373
Enterprise Value (EV)
0.00 481 1,484 1,223 2,220 3,570 2,675
Market Capitalization
180 180 1,768 1,335 2,313 3,686 2,422
Book Value per Share
$0.00 ($54.79) $3.91 $3.65 $3.41 $3.55 $3.45
Tangible Book Value per Share
$0.00 ($59.88) $3.24 $1.57 $1.48 $1.79 ($1.91)
Total Capital
0.00 205 369 419 325 357 713
Total Debt
0.00 25 25 85 0.00 0.00 351
Total Long-Term Debt
0.00 25 23 81 0.00 0.00 351
Net Debt
0.00 -142 -284 -112 -92 -116 252
Capital Expenditures (CapEx)
3.69 2.15 3.70 4.45 6.29 7.86 8.69
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 6.28 4.95 7.38 17 20 -1.42
Debt-free Net Working Capital (DFNWC)
0.00 173 314 204 109 136 98
Net Working Capital (NWC)
0.00 173 312 201 109 136 98
Net Nonoperating Expense (NNE)
12 27 17 18 18 9.60 10
Net Nonoperating Obligations (NNO)
0.00 -142 -284 -112 -92 -116 252
Total Depreciation and Amortization (D&A)
2.27 2.84 3.49 8.21 11 11 29
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.60% 3.25% 3.61% 6.43% 6.01% -0.32%
Debt-free Net Working Capital to Revenue
0.00% 154.33% 206.05% 99.74% 41.22% 40.68% 22.02%
Net Working Capital to Revenue
0.00% 154.05% 205.02% 98.18% 41.22% 40.68% 22.02%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.73) ($0.64) ($0.67) ($0.41) ($0.46)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 64.51M 90.96M 94.08M 98.89M 103.90M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.73) ($0.64) ($0.67) ($0.41) ($0.46)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 64.51M 90.96M 94.08M 98.89M 103.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 90.22M 92.30M 96.76M 102.23M 106.15M
Normalized Net Operating Profit after Tax (NOPAT)
-30 -24 -28 -49 -44 -31 -34
Normalized NOPAT Margin
-40.49% -21.39% -18.37% -24.06% -16.77% -9.32% -7.66%
Pre Tax Income Margin
-56.93% -45.79% -30.66% -28.91% -23.74% -12.14% -13.29%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-382.05 -104.13 -38.74 -14.97 -8.11 -96.80 -5.65
NOPAT to Interest Expense
-270.68 -50.25 -25.33 -10.44 -5.72 -67.76 -3.96
EBIT Less CapEx to Interest Expense
-415.59 -108.52 -41.86 -16.12 -8.91 -113.84 -6.57
NOPAT Less CapEx to Interest Expense
-304.21 -54.64 -28.45 -11.59 -6.53 -84.80 -4.87
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% -10.61% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -30.55% -27.73% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Alkami Technology

This table displays calculated financial ratios and metrics derived from Alkami Technology's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
30.15% 26.76% 28.50% 26.89% 24.93% 26.89% 25.62% 28.52% 36.39% 31.49% 34.73%
EBITDA Growth
13.25% 25.75% -283.84% 31.52% 30.10% 40.49% 41.75% -21.90% 29.60% 42.11% 82.19%
EBIT Growth
9.04% 21.59% -148.11% 26.79% 25.44% 33.09% 33.57% -25.65% -19.10% -23.52% -10.09%
NOPAT Growth
7.80% 20.34% -139.03% 27.03% 26.11% 33.95% 34.15% -24.51% -20.11% -23.52% -10.09%
Net Income Growth
12.22% 22.81% -158.82% 32.60% 30.65% 38.99% 39.88% 31.64% -10.34% -56.79% -49.69%
EPS Growth
13.64% 27.27% -180.00% 33.33% 31.58% 43.75% 50.00% 33.33% 0.00% -55.56% -57.14%
Operating Cash Flow Growth
48.69% 165.91% 61.63% 109.89% 109.60% 251.25% 215.19% -695.58% 111.13% 180.40% 171.74%
Free Cash Flow Firm Growth
80.52% 67.97% 88.08% 89.69% 45.58% 65.19% 26.37% -2,004.95% -2,036.91% -2,067.81% -2,514.58%
Invested Capital Growth
11.15% 19.97% 4.75% 4.41% 4.40% 4.38% 3.64% 156.39% 167.78% 149.53% 154.54%
Revenue Q/Q Growth
9.61% 2.95% 5.41% 6.67% 7.92% 4.56% 4.37% 9.12% 14.54% 0.80% 6.94%
EBITDA Q/Q Growth
-8.25% 15.77% 20.94% 5.01% -10.50% 28.30% 22.61% -98.78% 36.18% 41.04% 76.19%
EBIT Q/Q Growth
-6.73% 12.75% 16.68% 5.64% -8.70% 21.71% 17.28% -78.48% -3.03% 18.80% 26.28%
NOPAT Q/Q Growth
-5.47% 11.67% 17.03% 5.60% -6.81% 21.04% 17.28% -78.48% -3.03% 18.80% 26.28%
Net Income Q/Q Growth
-4.70% 12.87% 17.85% 10.07% -7.73% 23.34% 19.05% -2.26% -73.89% -8.93% 22.72%
EPS Q/Q Growth
-5.56% 15.79% 12.50% 14.29% -8.33% 30.77% 22.22% -14.29% -62.50% -7.69% 21.43%
Operating Cash Flow Q/Q Growth
40.61% 154.78% -269.60% 117.93% -42.38% 1,904.93% -44.38% -192.69% 120.43% 2,562.66% -46.10%
Free Cash Flow Firm Q/Q Growth
81.06% -45.41% 61.86% 1.81% 0.06% 6.97% 19.35% -2,707.11% -1.46% 5.62% 2.73%
Invested Capital Q/Q Growth
-5.46% 6.32% -4.67% 8.96% -5.47% 6.31% -5.34% 169.53% -1.27% -0.94% -3.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
53.94% 53.99% 55.98% 57.84% 59.36% 58.92% 59.35% 59.04% 58.56% 56.79% 57.19%
EBITDA Margin
-23.22% -19.00% -14.25% -12.69% -12.99% -8.91% -6.61% -12.03% -6.71% -3.92% -0.87%
Operating Margin
-27.18% -23.32% -18.35% -16.24% -16.07% -12.14% -9.62% -15.74% -14.16% -11.40% -7.86%
EBIT Margin
-27.16% -23.02% -18.20% -16.10% -16.21% -12.14% -9.62% -15.74% -14.16% -11.40% -7.86%
Profit (Net Income) Margin
-27.01% -22.86% -17.81% -15.02% -14.99% -10.99% -8.52% -7.99% -12.13% -13.11% -9.47%
Tax Burden Percent
100.50% 100.25% 97.85% 101.68% 101.52% 99.80% 99.39% 51.76% 75.98% 99.80% 102.69%
Interest Burden Percent
98.94% 99.04% 100.05% 91.77% 91.09% 90.73% 89.15% 98.08% 112.76% 115.15% 117.32%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-20.47% -18.15% -14.95% -12.86% -14.25% -10.74% -9.48% -8.66% -8.66% -7.39% -5.71%
ROIC Less NNEP Spread (ROIC-NNEP)
-15.73% -13.77% -11.48% -9.27% -10.84% -8.08% -7.94% -6.27% -11.02% -13.11% -12.74%
Return on Net Nonoperating Assets (RNNOA)
5.30% 4.28% 3.55% 2.20% 3.01% 1.97% 2.42% -2.36% -3.46% -3.85% -2.42%
Return on Equity (ROE)
-15.17% -13.88% -11.40% -10.67% -11.25% -8.77% -7.06% -11.02% -12.12% -11.24% -8.12%
Cash Return on Invested Capital (CROIC)
-29.85% -35.69% -24.23% -20.98% -20.54% -18.06% -16.75% -95.14% -99.23% -93.85% -95.95%
Operating Return on Assets (OROA)
-13.23% -11.85% -10.84% -10.28% -11.00% -8.47% -7.67% -9.06% -8.77% -7.48% -5.43%
Return on Assets (ROA)
-13.15% -11.77% -10.62% -9.59% -10.17% -7.67% -6.80% -4.60% -7.51% -8.60% -6.54%
Return on Common Equity (ROCE)
-15.17% -13.88% -11.40% -10.67% -11.25% -8.77% -7.06% -11.02% -12.12% -11.24% -8.12%
Return on Equity Simple (ROE_SIMPLE)
-18.51% -17.13% 0.00% -17.77% -15.87% -13.56% 0.00% -11.14% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-13 -11 -9.17 -8.66 -9.24 -7.30 -6.04 -11 -11 -9.02 -6.65
NOPAT Margin
-19.02% -16.32% -12.85% -11.37% -11.25% -8.50% -6.73% -11.02% -9.91% -7.98% -5.50%
Net Nonoperating Expense Percent (NNEP)
-4.74% -4.39% -3.48% -3.60% -3.41% -2.66% -1.54% -2.40% 2.36% 5.72% 7.03%
Return On Investment Capital (ROIC_SIMPLE)
- - -2.82% - - - -1.69% -1.45% -1.52% -1.24% -0.93%
Cost of Revenue to Revenue
46.06% 46.01% 44.02% 42.16% 40.64% 41.08% 40.65% 40.96% 41.44% 43.21% 42.81%
SG&A Expenses to Revenue
27.69% 27.02% 27.03% 25.37% 25.09% 25.78% 24.07% 24.30% 23.24% 22.70% 21.06%
R&D to Revenue
31.73% 32.13% 30.11% 29.98% 29.10% 28.09% 28.27% 27.48% 26.98% 26.64% 25.82%
Operating Expenses to Revenue
81.12% 77.30% 74.33% 74.08% 75.44% 71.06% 68.97% 74.77% 72.71% 68.19% 65.05%
Earnings before Interest and Taxes (EBIT)
-18 -16 -13 -12 -13 -10 -8.63 -15 -16 -13 -9.50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-15 -13 -10 -9.66 -11 -7.65 -5.92 -12 -7.51 -4.43 -1.06
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.72 5.34 7.12 7.36 8.49 9.22 10.32 8.03 9.03 7.38 6.69
Price to Tangible Book Value (P/TBV)
11.25 12.61 16.39 16.89 18.93 19.54 20.48 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
6.48 6.90 8.73 8.46 9.34 9.89 11.04 7.55 8.06 6.27 5.46
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
6.22 6.71 9.54 9.10 11.22 11.92 14.80 4.61 5.30 4.51 4.35
Enterprise Value to Revenue (EV/Rev)
6.09 6.58 8.38 8.22 9.05 9.63 10.69 8.44 8.83 6.96 6.03
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 423.12 191.99 250.37 270.28 88.59 62.34
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.26 0.31 0.00 0.06 0.00 0.05 0.00 1.23 1.12 1.08 0.97
Long-Term Debt to Equity
0.24 0.29 0.00 0.06 0.00 0.05 0.00 1.23 1.12 1.08 0.97
Financial Leverage
-0.34 -0.31 -0.31 -0.24 -0.28 -0.24 -0.30 0.38 0.31 0.29 0.19
Leverage Ratio
1.46 1.49 1.35 1.35 1.35 1.37 1.23 1.88 1.85 1.83 1.79
Compound Leverage Factor
1.45 1.48 1.35 1.24 1.23 1.24 1.09 1.84 2.09 2.10 2.10
Debt to Total Capital
20.56% 23.86% 0.00% 5.30% 0.00% 4.89% 0.00% 55.20% 52.82% 51.84% 49.24%
Short-Term Debt to Total Capital
1.31% 1.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.25% 22.35% 0.00% 5.30% 0.00% 4.89% 0.00% 55.20% 52.82% 51.84% 49.24%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
79.44% 76.14% 100.00% 94.70% 100.00% 95.11% 100.00% 44.80% 47.18% 48.16% 50.76%
Debt to EBITDA
-1.69 -2.25 0.00 -0.38 0.00 -0.46 0.00 -11.43 -11.72 -12.71 -14.18
Net Debt to EBITDA
1.88 1.73 0.00 1.44 0.00 2.19 0.00 -8.78 -9.07 -9.65 -10.18
Long-Term Debt to EBITDA
-1.58 -2.10 0.00 -0.38 0.00 -0.46 0.00 -11.43 -11.72 -12.71 -14.18
Debt to NOPAT
-1.98 -2.57 0.00 -0.44 0.00 -0.51 0.00 -12.34 -10.94 -10.20 -9.35
Net Debt to NOPAT
2.21 1.97 0.00 1.67 0.00 2.43 0.00 -9.48 -8.46 -7.74 -6.72
Long-Term Debt to NOPAT
-1.86 -2.41 0.00 -0.44 0.00 -0.51 0.00 -12.34 -10.94 -10.20 -9.35
Altman Z-Score
5.71 6.06 17.89 18.45 21.10 21.84 27.11 2.91 3.48 2.92 2.76
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.44 4.73 3.77 3.92 3.75 3.52 3.98 2.75 2.68 2.17 2.09
Quick Ratio
4.91 4.26 3.24 3.31 3.12 2.99 3.39 2.25 2.03 1.76 1.68
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-36 -52 -20 -19 -19 -18 -15 -407 -413 -390 -380
Operating Cash Flow to CapEx
-334.31% 203.25% -316.72% 56.98% 26.38% 477.90% 337.62% -293.32% 53.59% 1,327.32% 728.97%
Free Cash Flow to Firm to Interest Expense
-19.47 -26.77 -8.65 -265.18 -261.44 -99.99 -108.33 -508.72 -129.68 -131.02 -150.67
Operating Cash Flow to Interest Expense
-3.13 1.62 -2.33 13.03 7.41 61.04 45.60 -7.07 0.36 10.34 6.59
Operating Cash Flow Less CapEx to Interest Expense
-4.06 0.82 -3.06 -9.84 -20.66 48.27 32.10 -9.48 -0.31 9.57 5.69
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.49 0.51 0.60 0.64 0.68 0.70 0.80 0.58 0.62 0.66 0.69
Accounts Receivable Turnover
8.46 8.65 8.58 8.76 8.86 8.57 8.99 8.62 8.90 8.86 9.83
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
16.29 16.76 17.36 17.33 17.07 16.93 17.11 17.26 17.63 17.75 18.21
Accounts Payable Turnover
45.87 26.08 20.51 25.78 37.44 23.43 20.17 24.79 25.32 26.73 31.25
Days Sales Outstanding (DSO)
43.17 42.19 42.55 41.67 41.18 42.61 40.58 42.35 41.02 41.18 37.12
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
7.96 13.99 17.79 14.16 9.75 15.58 18.10 14.72 14.41 13.65 11.68
Cash Conversion Cycle (CCC)
35.21 28.20 24.76 27.51 31.44 27.03 22.49 27.63 26.60 27.53 25.44
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
230 244 233 254 240 255 241 650 642 636 614
Invested Capital Turnover
1.08 1.11 1.16 1.13 1.27 1.26 1.41 0.79 0.87 0.93 1.04
Increase / (Decrease) in Invested Capital
23 41 11 11 10 11 8.48 397 402 381 373
Enterprise Value (EV)
1,429 1,639 2,220 2,308 2,690 3,038 3,570 3,000 3,403 2,871 2,675
Market Capitalization
1,522 1,717 2,313 2,377 2,777 3,122 3,686 2,684 3,105 2,585 2,422
Book Value per Share
$3.47 $3.41 $3.41 $3.34 $3.36 $3.42 $3.55 $3.27 $3.34 $3.36 $3.45
Tangible Book Value per Share
$1.46 $1.44 $1.48 $1.45 $1.50 $1.61 $1.79 ($2.40) ($2.25) ($2.10) ($1.91)
Total Capital
406 422 325 341 327 356 357 746 729 727 713
Total Debt
83 101 0.00 18 0.00 17 0.00 412 385 377 351
Total Long-Term Debt
78 94 0.00 18 0.00 17 0.00 412 385 377 351
Net Debt
-93 -77 -92 -69 -87 -84 -116 316 298 286 252
Capital Expenditures (CapEx)
1.71 1.54 1.68 1.67 2.08 2.30 1.81 1.93 2.16 2.32 2.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)
14 12 17 21 24 20 20 16 24 3.33 -1.42
Debt-free Net Working Capital (DFNWC)
190 190 109 108 111 121 136 111 111 94 98
Net Working Capital (NWC)
185 183 109 108 111 121 136 111 111 94 98
Net Nonoperating Expense (NNE)
5.25 4.43 3.54 2.78 3.07 2.14 1.60 -2.96 2.49 5.79 4.79
Net Nonoperating Obligations (NNO)
-93 -77 -92 -69 -87 -84 -116 316 298 286 252
Total Depreciation and Amortization (D&A)
2.60 2.73 2.82 2.59 2.65 2.78 2.70 3.62 8.35 8.45 8.44
Debt-free, Cash-free Net Working Capital to Revenue
5.84% 4.66% 6.43% 7.53% 8.09% 6.33% 6.01% 4.40% 6.31% 0.81% -0.32%
Debt-free Net Working Capital to Revenue
80.96% 76.25% 41.22% 38.60% 37.48% 38.33% 40.68% 31.21% 28.91% 22.85% 22.02%
Net Working Capital to Revenue
78.69% 73.69% 41.22% 38.60% 37.48% 38.33% 40.68% 31.21% 28.91% 22.85% 22.02%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.19) ($0.16) ($0.14) ($0.12) ($0.13) ($0.09) ($0.07) ($0.08) ($0.13) ($0.14) ($0.11)
Adjusted Weighted Average Basic Shares Outstanding
93.33M 94.68M 94.08M 96.95M 98.10M 99.44M 98.89M 102.43M 103.39M 104.35M 103.90M
Adjusted Diluted Earnings per Share
($0.19) ($0.16) ($0.14) ($0.12) ($0.13) ($0.09) ($0.07) ($0.08) ($0.13) ($0.14) ($0.11)
Adjusted Weighted Average Diluted Shares Outstanding
93.33M 94.68M 94.08M 96.95M 98.10M 99.44M 98.89M 102.43M 103.39M 104.35M 103.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
94.23M 95.36M 96.76M 97.52M 98.99M 100.50M 102.23M 103.02M 104.08M 105.00M 106.15M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -11 -9.14 -8.61 -9.15 -7.30 -6.04 -7.95 -11 -8.84 -6.42
Normalized NOPAT Margin
-18.99% -16.32% -12.81% -11.31% -11.14% -8.50% -6.73% -8.13% -9.59% -7.83% -5.31%
Pre Tax Income Margin
-26.87% -22.80% -18.20% -14.77% -14.77% -11.01% -8.58% -15.44% -15.96% -13.13% -9.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-9.78 -8.07 -5.70 -167.85 -179.99 -57.93 -64.37 -19.22 -4.98 -4.33 -3.77
NOPAT to Interest Expense
-6.85 -5.72 -4.02 -118.57 -124.93 -40.55 -45.06 -13.45 -3.48 -3.03 -2.64
EBIT Less CapEx to Interest Expense
-10.72 -8.87 -6.43 -190.71 -208.05 -70.71 -77.88 -21.63 -5.65 -5.10 -4.67
NOPAT Less CapEx to Interest Expense
-7.79 -6.52 -4.76 -141.43 -153.00 -53.33 -58.57 -15.87 -4.16 -3.81 -3.54
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here is MarketBeat's concise trend analysis of Alkami Technology (ALKT) using the last four years of quarterly statements. Focus is on revenue, cash flow, profitability, and balance-sheet signals for retail investors.

  • Revenue growth: ALKT’s quarterly operating revenue has expanded from about $55.5 million in Q4 2022 to $120.8 million in Q4 2025, roughly a 117% increase over the period.
  • Operating cash flow turned positive in the latest quarter: Net cash from continuing operating activities was $16,606,000 in Q4 2025. This marks a shift to cash-generating operations despite ongoing losses on the income statement.
  • Free cash flow potential: Using operating cash flow minus capex, FCF for Q4 2025 is approximately $14.3 million, indicating cash generation after essential investments.
  • Maintained gross profitability: Total gross profit in Q4 2025 was $69,079,000 on $120,791,000 in revenue, implying a gross margin around 57%—a solid level given growth.
  • R&D investment rising: R&D expense was $31.189 million in Q4 2025, up from about $25.3 million in Q3 2025 and higher than prior years, signaling ongoing product development focus.
  • Leverage remains sizable: Long-term debt and total liabilities have stayed substantial across 2022–2025, illustrating continued leverage rather than rapid deleveraging.
  • Profitability still under pressure: Net income in Q4 2025 remained negative at -$11.441 million, underscoring ongoing profitability challenges despite revenue growth.
  • Operating income negative: In Q4 2025, total operating income was -$9.496 million, showing the core business remains unprofitable at the operating level.
  • Earnings per share negative: Basic and diluted earnings per share were -$0.11 in Q4 2025, with about 103.9 million weighted average shares outstanding, highlighting ongoing losses per share.
  • Financing activities outflow: Net cash from financing activities in Q4 2025 was -$6,335,000, reflecting financing outflows and debt-related cash needs.
05/06/26 12:10 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Alkami Technology's Financials

When does Alkami Technology's financial year end?

According to the most recent income statement we have on file, Alkami Technology's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Alkami Technology's net income changed over the last 6 years?

Alkami Technology's net income were at -$47.65 million at the end of 2025, a 16.7% increase from 2024, and a 13.8% increase since 2019. Check out Alkami Technology's forecast to explore projected trends and price targets.

What is Alkami Technology's operating income?
Alkami Technology's total operating income in 2025 was -$53.64 million, based on the following breakdown:
  • Total Gross Profit: $256.60 million
  • Total Operating Expenses: $310.24 million
How has Alkami Technology's revenue changed over the last 6 years?

Over the last 6 years, Alkami Technology's total revenue changed from $73.54 million in 2019 to $443.64 million in 2025, a change of 503.3%.

How much debt does Alkami Technology have?

Alkami Technology's total liabilities were at $485.18 million at the end of 2025, a 504.6% increase from 2024, and a 598.8% increase since 2020.

How much cash does Alkami Technology have?

In the past 5 years, Alkami Technology's cash and equivalents has ranged from $40.93 million in 2023 to $308.58 million in 2021, and is currently $63.46 million as of their latest financial filing in 2025.

How has Alkami Technology's book value per share changed over the last 6 years?

Over the last 6 years, Alkami Technology's book value per share changed from 0.00 in 2019 to 3.45 in 2025, a change of 344.8%.



Financial statements for NASDAQ:ALKT last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners